MindImmune Therapeutics, Inc. — Form D

MindImmune Therapeutics, Inc. of KINGSTON, RI, a company, filed a Form D exempt-offering notice with the SEC on 2019-11-01. The offering totals $3.0M, of which $750K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
Richard G HoranDirectorKingston, RI
Frank S MennitiDirectorKingston, RI
Robert B NelsonDirectorKingston, RI
Frank S MennitiExecutive OfficerKingston, RI
Isaac StonerDirectorKingston, RI
Isaac StonerExecutive OfficerKingston, RI
Isaac StonerRelated PersonKingston, RI
Reetika BhardwajDirectorKingston, RI
Reetika BhardwajRelated PersonKingston, RI
Christopher O'DonnellDirectorKingston, RI
Christopher O'DonnellRelated PersonKingston, RI
Robert NelsonExecutive OfficerShreveport, LA
Bradley MargusDirectorKingston, RI
Bradley MargusRelated PersonKingston, RI
Robert B NelsonExecutive OfficerKingston, RI
Tracy SaxtonDirectorKingston, RI
Stevin ZornDirectorKingston, RI
Stevin ZornExecutive OfficerKingston, RI
Diane GoodingExecutive OfficerKingston, RI

Other filings by this issuer (3)

FiledFormOfferingSold
2026-03-05D/A$17.0M$15.2M
2025-12-05D$12.0M$10.2M
2022-02-04D$8.9M$5.3M

More